Chongqing, a key economic hub in southwest China, has unveiled a plan to support the development of innovative drugs as…
Read More »innovative drugs
Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group, two of China’s largest drug makers, are expected to report significantly improved profits,…
Read More »
GlaxoSmithKline (GSK) will pay a Chinese company US$12.5 billion for exclusive global rights to develop a dozen drugs, in a…
Read More »
Beijing’s plan to publish China’s first list of innovative drugs eligible for coverage by commercial health insurance will draw keen…
Read More »
Shares of Chinese cancer drug developer Akeso slumped on Monday despite the company receiving a second marketing approval from the…
Read More »
When the stock markets in Hong Kong and mainland China resumed trading after a long weekend on Monday, traders knew…
Read More »
Licensing deals struck by Chinese biotech start-ups with overseas partners could potentially fetch billions in revenue if their drug candidates…
Read More »
China has added dozens of new drugs to its health insurance reimbursement list, signalling support for innovative treatments while keeping…
Read More »